<DOC>
	<DOCNO>NCT02307175</DOCNO>
	<brief_summary>Prospective , open label single site study demonstrate safety efficacy Tc-99m pertechnetate produce high energy cyclotron CHUS .</brief_summary>
	<brief_title>A Study 99m Tc Pertechnetate Produced High Energy Cyclotron Patients With Thyroid Scan Indication</brief_title>
	<detailed_description>The propose clinical trial prospective , case-controlled Phase I , open label , single site study . The first 10 consecutively enrolled patient receive CYCLOTEC standard procedure thyroid imagery additional whole-body scan , 20 subsequent case-matched control , receive GPERT also additionnal whole body scan .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Congenital Hypothyroidism</mesh_term>
	<mesh_term>Sodium Pertechnetate Tc 99m</mesh_term>
	<criteria>Prescribed thyroid scan Provided write informed consent prior participation Biochemical parameter within 5 time normal limit age WBC count &gt; 3.0/μL ANC count 1.5/μL Platelets &gt; 75,000/μL Haemoglobin &gt; 10 g/dL Karnofsky Performance Scale score &gt; 50 Nursing pregnant female Biochemical parameter measure outside 5 time normal limit age within 14 day scan WBC &lt; 3.0/μL ANC &lt; 1.5/μL Platelets &lt; 75,000/μL Haemoglobin &lt; 10 g/dL Unable unwilling follow instruction comply protocol Unable unwilling provide write informed consent prior participation study Karnofsky Performance Scale score &lt; 50</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>